Drug Interaction Study of Digoxin and BI 10773

NCT01306175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Digoxin plus BI 10773
DRUG: Digoxin

Sponsor

Boehringer Ingelheim